UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Consolidated Planning Corp

Consolidated Planning Corp boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% during the 4th quarter, HoldingsChannel reports. The fund owned 15,079 shares of the healthcare conglomerate’s stock after buying an additional 107 shares during the period. UnitedHealth Group comprises 1.5% of Consolidated Planning Corp’s portfolio, making the stock its 19th largest position. Consolidated Planning Corp’s holdings in UnitedHealth Group were worth $7,939,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Alliance Wealth Advisors LLC UT grew its position in shares of UnitedHealth Group by 1.3% during the fourth quarter. Alliance Wealth Advisors LLC UT now owns 5,495 shares of the healthcare conglomerate’s stock worth $2,893,000 after acquiring an additional 69 shares during the last quarter. Dohj LLC grew its position in shares of UnitedHealth Group by 5.6% during the fourth quarter. Dohj LLC now owns 5,749 shares of the healthcare conglomerate’s stock worth $3,027,000 after acquiring an additional 306 shares during the last quarter. Valmark Advisers Inc. grew its position in shares of UnitedHealth Group by 5.6% during the fourth quarter. Valmark Advisers Inc. now owns 6,178 shares of the healthcare conglomerate’s stock worth $3,252,000 after acquiring an additional 326 shares during the last quarter. Stuart Chaussee & Associates Inc. grew its position in shares of UnitedHealth Group by 60.7% during the fourth quarter. Stuart Chaussee & Associates Inc. now owns 98 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 37 shares during the last quarter. Finally, Addison Advisors LLC grew its position in shares of UnitedHealth Group by 23.0% during the fourth quarter. Addison Advisors LLC now owns 374 shares of the healthcare conglomerate’s stock worth $197,000 after acquiring an additional 70 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Up 0.3 %

UNH stock traded up $1.49 during mid-day trading on Friday, reaching $495.35. 2,727,016 shares of the stock traded hands, compared to its average volume of 5,623,667. The company has a market cap of $455.76 billion, a P/E ratio of 30.28, a P/E/G ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The stock’s fifty day moving average is $485.84 and its 200-day moving average is $514.21.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.26 EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Analyst Ratings Changes

UNH has been the subject of a number of recent analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research report on Monday, April 8th. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday, April 19th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Finally, Oppenheimer reissued an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a report on Wednesday, January 17th. Four analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.